Dominic Sinibaldi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dominic Sinibaldi

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Oncogene|December 17, 2002

Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cellsMei Huang, Jay F Dorsey, P K Epling-Burnette, et al.

Annals of the Rheumatic Diseases|February 19, 2017

A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritisGerd R Burmester, Iain B McInnes, Joel Kremer, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026

Multi-omic profiling reveals immune cell priming signature linked to lupus prognosisMichael A Smith, Dominic Sinibaldi, Saifur Rahman, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Oncogene|December 17, 2002

Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cellsMei Huang, Jay F Dorsey, P K Epling-Burnette, et al.

Annals of the Rheumatic Diseases|February 19, 2017

A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritisGerd R Burmester, Iain B McInnes, Joel Kremer, et al.

Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026

Multi-omic profiling reveals immune cell priming signature linked to lupus prognosisMichael A Smith, Dominic Sinibaldi, Saifur Rahman, et al.

Pageof 2